Skip to content

Transcranial versus Direct Cortical Stimulation for Motor Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (the TRANSEKT-Trial), a Randomized Controlled Study

Transcranial versus Direct Cortical Stimulation for Motor Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (the TRANSEKT-Trial), a Randomized Controlled Study - TRANSEKT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023256
Enrollment
120
Registered
2020-10-29
Start date
2020-12-03
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C71.0 C71.1 C71.2 C71.3

Interventions

Group 1: Resection of a supratentorial tumor under transcranial electrical stimulation for monitoring of motor evoked potentials Group 2: Resection of a supratentorial tumor under direct cortical stim

Sponsors

Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1- Indication for surgical resection of a supratentorial tumor. 2- Suspected supratentorial glioma or metastasis in close vicinity to the corticospinal tract without Infiltration of the precentral gyrus, confirmed in a preoperative magnetic resonance imaging. 3- Missing or mild preoperative paresis (MRC grades 5 or 4) 4- Age => 18 and =< 80 years 5- Ability to give informed consent.

Exclusion criteria

Exclusion criteria: 1- Age 80 years 2- Preoperative MRI is not available 3- Severe preoperative paralysis (MRC grades 1,2 or 3) 4- One of the stimulation modalities is not appropriate for intraoperative application according to the neurosurgeon.

Design outcomes

Primary

MeasureTime frame
Sensitivity and specificity of direct cortical and transcranial stimulation, in terms of predicting motor findings upon discharge or 7 days after surgery.

Secondary

MeasureTime frame
1-Extent of tumor resection. 2-Clinical motor status 24 hours after surgery, on discharge (or 7 days after surgery) and after 3 months. 3-Barthel Index and Karnofsky performance Score, on discharge and after 3 months. 4-Self reported quality of life (EORTC QOL C30) and depressiveness (BDI-V) 3 months after surgery.

Countries

Germany, Switzerland

Contacts

Public ContactTammam Abboud

Universitätsmedizin Göttingen

tammam.abboud@med.uni-goettingen.de0551-39-65246

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026